Emergence of a SARS-CoV-2 E484K variant of interest in Arizona
Peter T. Skidmore, Emily A. Kaelin, LaRinda A. Holland, Rabia Maqsood, Lily I. Wu, Nicholas J. Mellor, Joy M. Blain, Valerie Harris, Joshua LaBaer, Vel Murugan, View ORCID ProfileEfrem S. Lim
doi: https://doi.org/10.1101/2021.03.26.21254367
Peter T. Skidmore
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Emily A. Kaelin
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
2School of Life Sciences, Arizona State University, Tempe, Arizona, USA
LaRinda A. Holland
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Rabia Maqsood
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Lily I. Wu
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Nicholas J. Mellor
3OKED Biosciences Genomics Core Facility, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Joy M. Blain
3OKED Biosciences Genomics Core Facility, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Valerie Harris
4Virginia G. Piper Center for Personalized Diagnostics, and ASU Biodesign Clinical testing Laboratory, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Joshua LaBaer
4Virginia G. Piper Center for Personalized Diagnostics, and ASU Biodesign Clinical testing Laboratory, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Vel Murugan
4Virginia G. Piper Center for Personalized Diagnostics, and ASU Biodesign Clinical testing Laboratory, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Efrem S. Lim
1Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
2School of Life Sciences, Arizona State University, Tempe, Arizona, USA
Data Availability
Sequence data have been deposited in GISAID.
Posted March 28, 2021.
Emergence of a SARS-CoV-2 E484K variant of interest in Arizona
Peter T. Skidmore, Emily A. Kaelin, LaRinda A. Holland, Rabia Maqsood, Lily I. Wu, Nicholas J. Mellor, Joy M. Blain, Valerie Harris, Joshua LaBaer, Vel Murugan, Efrem S. Lim
medRxiv 2021.03.26.21254367; doi: https://doi.org/10.1101/2021.03.26.21254367
Emergence of a SARS-CoV-2 E484K variant of interest in Arizona
Peter T. Skidmore, Emily A. Kaelin, LaRinda A. Holland, Rabia Maqsood, Lily I. Wu, Nicholas J. Mellor, Joy M. Blain, Valerie Harris, Joshua LaBaer, Vel Murugan, Efrem S. Lim
medRxiv 2021.03.26.21254367; doi: https://doi.org/10.1101/2021.03.26.21254367
Subject Area
Subject Areas
- Addiction Medicine (371)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12400)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4261)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2757)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4037)
- Nursing (216)
- Nutrition (599)
- Oncology (2127)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)